GARTHILL DEVELOPMENTS LIMITED

Company number SC113552 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£300k -£200k -£100k £0 £100k £200k £300k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £164,798 Total assets 2017: £167,282 Total assets 2018: £162,625 Total assets 2019: £175,945 Total assets 2020: £256,017 Total assets 2021: £202,928 Total assets 2022: £158,947 Total assets 2023: £158,615 Total assets 2024: £207,227 Total assets 2025: £283,066 Total assets Net assets 2016: £88,732 Net assets 2017: £81,360 Net assets 2018: £76,385 Net assets 2023: £59,377 Net assets 2024: £56,273 Net assets 2025: £43,486 Net assets Total liabilities 2016: -£76,066 Total liabilities 2017: -£78,254 Total liabilities 2018: -£82,572 Total liabilities 2019: -£106,099 Total liabilities 2020: -£162,409 Total liabilities 2021: -£117,479 Total liabilities 2022: -£90,233 Total liabilities 2023: -£99,238 Total liabilities 2024: -£134,012 Total liabilities 2025: -£227,058 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 0 1 2024 2025 2024: 0 2025: 0

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 13 years

Latest accounts (2025-09-30): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-09-30 £283,066 -£227,058 £43,486 0
2024-09-30 £207,227 -£134,012 £56,273 0
2023-09-30 £158,615 -£99,238 £59,377
2022-09-30 £158,947 -£90,233
2021-09-30 £202,928 -£117,479
2020-09-30 £256,017 -£162,409
2019-09-30 £175,945 -£106,099
2018-09-30 £162,625 -£82,572 £76,385
2017-09-30 £167,282 -£78,254 £81,360
2016-09-30 £164,798 -£76,066 £88,732
2015-09-30 £154,769 -£68,068 £24,842
2014-09-30 £171,615 -£69,366 £102,391 £43,415
2013-09-30 £316,037 -£144,120 £173,586 £69,196

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.